EP1144441A3 - Disintegrin homologs - Google Patents
Disintegrin homologsInfo
- Publication number
- EP1144441A3 EP1144441A3 EP99933873A EP99933873A EP1144441A3 EP 1144441 A3 EP1144441 A3 EP 1144441A3 EP 99933873 A EP99933873 A EP 99933873A EP 99933873 A EP99933873 A EP 99933873A EP 1144441 A3 EP1144441 A3 EP 1144441A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- disintegrin
- homologs
- disintegrin homologs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Surgery (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11388398A | 1998-07-10 | 1998-07-10 | |
US113883 | 1998-07-10 | ||
PCT/US1999/015638 WO2000002912A2 (en) | 1998-07-10 | 1999-07-09 | Disintegrin homologs |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1144441A2 EP1144441A2 (en) | 2001-10-17 |
EP1144441A3 true EP1144441A3 (en) | 2001-11-28 |
Family
ID=22352096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99933873A Withdrawn EP1144441A3 (en) | 1998-07-10 | 1999-07-09 | Disintegrin homologs |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1144441A3 (en) |
JP (1) | JP2002526033A (en) |
AU (1) | AU4983399A (en) |
CA (1) | CA2332311A1 (en) |
IL (1) | IL140607A0 (en) |
WO (1) | WO2000002912A2 (en) |
ZA (1) | ZA200007766B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ506817A (en) | 1998-02-11 | 2003-08-29 | Immunex Corp | Metalloprotease-disintegrin SVPH3-13 and SVPH3-17 nucleic acids, and their corresponding polypeptides and methods for their production |
WO2001074857A2 (en) * | 2000-04-03 | 2001-10-11 | Bristol-Myers Squibb Company | Methods and compositions for modulating integrin-mediated cell-cell interactions |
US20020081685A1 (en) * | 2000-08-03 | 2002-06-27 | Fox Brian A. | Disintegrin homologs, ZSNK10, ZSNK11, and ZSNK12 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9608130D0 (en) * | 1996-04-19 | 1996-06-26 | Univ Sheffield | Adam proteins and uses thereof |
JPH11155574A (en) * | 1997-12-01 | 1999-06-15 | Eisai Co Ltd | New protein belonging to mdc gene family and dna coding for the protein |
NZ506817A (en) * | 1998-02-11 | 2003-08-29 | Immunex Corp | Metalloprotease-disintegrin SVPH3-13 and SVPH3-17 nucleic acids, and their corresponding polypeptides and methods for their production |
-
1999
- 1999-07-09 IL IL14060799A patent/IL140607A0/en unknown
- 1999-07-09 WO PCT/US1999/015638 patent/WO2000002912A2/en active Application Filing
- 1999-07-09 EP EP99933873A patent/EP1144441A3/en not_active Withdrawn
- 1999-07-09 AU AU49833/99A patent/AU4983399A/en not_active Abandoned
- 1999-07-09 JP JP2000559141A patent/JP2002526033A/en active Pending
- 1999-07-09 CA CA002332311A patent/CA2332311A1/en not_active Abandoned
-
2000
- 2000-12-21 ZA ZA200007766A patent/ZA200007766B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000002912A2 (en) | 2000-01-20 |
EP1144441A2 (en) | 2001-10-17 |
IL140607A0 (en) | 2002-02-10 |
AU4983399A (en) | 2000-02-01 |
ZA200007766B (en) | 2001-12-21 |
WO2000002912A3 (en) | 2001-09-07 |
JP2002526033A (en) | 2002-08-20 |
CA2332311A1 (en) | 2000-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3485999A (en) | Neo-tryptophan | |
AU9392998A (en) | Pack-a-pillow | |
AU5290999A (en) | Simplified window-raiser - | |
AU3522399A (en) | Carvedilol-galenics | |
AU3437799A (en) | City-car | |
AU3253699A (en) | Myxochelines | |
AU5407599A (en) | Sphingolipid-desaturase | |
AU8363398A (en) | Capotasto | |
AU5998199A (en) | New bis-benzimidazoles | |
EP0938928A3 (en) | Showers | |
AU2609599A (en) | Sensor-coupling | |
EP1144441A3 (en) | Disintegrin homologs | |
AU3204999A (en) | Futureball | |
AU2069199A (en) | Codelets | |
AU1055399A (en) | Rollerboard | |
AU3347599A (en) | Aeromobile | |
AU9347498A (en) | Imidazotriazolopyrimidines | |
AU5223199A (en) | Bathtub-bathseat | |
AU1912300A (en) | Lipocalin homologs | |
AU2840799A (en) | 1-phosphanorbornadienes | |
AU3819799A (en) | Methoximinomethyloxathiazines | |
AU9218098A (en) | Exocyclic-phosphoethanolamines | |
AU1779099A (en) | Heterocyclyl-derivatives | |
AU4768799A (en) | Bookcover | |
AUPP314598A0 (en) | Shoe two |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
17P | Request for examination filed |
Effective date: 20010105 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
XX | Miscellaneous (additional remarks) |
Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR. |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20041220 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20071214 |